Abstract
Objective: Sex is an important predictor for lung cancer survival and a favorable prognostic indicator for women compared to men. Specific surgery-related sex differences of patients with lung cancer remain unclear. The aim of this study is to analyze sex-specific differences after lung cancer resections to identify factors for an unfavorable prognosis. Methods: This is a retrospective analysis of a German nationwide discharge register of every adult inpatient undergoing pulmonary resection for lung cancer from 2014 until 2017. DRG data and OPS procedures were analyzed with the help of the Federal Statistical Office using remote controlled data. A multivariable regression model was established in a stepwise process to evaluate the effect of sex on inpatient mortality. Results: A total of 38,806 patients underwent surgical resection for lung cancer between January 2014 and December 2017 in Germany. Women were significantly younger at admission than men (mean 64.7 years [SD 10.1] vs. 66.6 years [SD 9.5]; p < 0.0001). They had fewer unreferred admissions (risk ratio 0.83 [0.77, 0.90], p < 0.0001) and were significantly less likely to have recorded comorbidities. Raw in-hospital mortality was 1.8% for women and 4.1% for men. In the multivariable analysis of in-hospital mortality, the likelihood of death for women compared to men was 21% reduced (OR 0.79 [CI: 0.66, 0.93, p = 0.005]). The risk of postoperative complications such as ventilation >48 h, ARDS, tracheotomy, or pneumonia was significantly lower for women. Conclusions: Women undergoing lung cancer surgery were younger and had less comorbidities than men in Germany. Female sex was associated with lower mortality and less postoperative complications.
References
1.
Howlader
N
, Forjaz
G
, Mooradian
MJ
, Meza
R
, Kong
CY
, Cronin
KA
, The effect of advances in lung-cancer treatment on population mortality
. N Engl J Med
. 2020
;383
(7
):640
–9
.2.
Fu
JB
, Kau
TY
, Severson
RK
, Kalemkerian
GP
. Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database
. Chest
. 2005
;127
(3
):768
–77
.3.
Visbal
AL
, Williams
BA
, Nichols
FC
3rd, Marks
RS
, Jett
JR
, Aubry
MC
, Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002
. Ann Thorac Surg
. 2004
;78
(1
):209
–15
; discussion 215.4.
Jemal
A
, Miller
KD
, Ma
J
, Siegel
RL
, Fedewa
SA
, Islami
F
, Higher lung cancer incidence in young women than young men in the United States
. N Engl J Med
. 2018
;378
(21
):1999
–2009
.5.
Sakurai
H
, Asamura
H
, Goya
T
, Eguchi
K
, Nakanishi
Y
, Sawabata
N
, Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study
. J Thorac Oncol
. 2010
;5
(10
):1594
–601
.6.
Yoshida
Y
, Murayama
T
, Sato
Y
, Suzuki
Y
, Saito
H
, Nomura
Y
. Gender differences in long-term survival after surgery for non-small cell lung cancer
. Thorac Cardiovasc Surg
. 2016
;64
(6
):507
–14
.7.
Guo
NL
, Tosun
K
, Horn
K
. Impact and interactions between smoking and traditional prognostic factors in lung cancer progression
. Lung Cancer
. 2009
;66
(3
):386
–92
. .8.
Olak
J
, Colson
Y
. Gender differences in lung cancer: have we really come a long way, baby?
J Thorac Cardiovasc Surg
. 2004
;128
(3
):346
–51
. .9.
Ye
Y
, Jing
Y
, Li
L
, Mills
GB
, Diao
L
, Liu
H
, Sex-associated molecular differences for cancer immunotherapy
. Nat Commun
. 2020
;11
(1
):1779
.10.
Sun
S
, Schiller
JH
, Gazdar
AF
. Lung cancer in never smokers: a different disease
. Nat Rev Cancer
. 2007
;7
(10
):778
–90
. .11.
Rana
RH
, Alam
F
, Alam
K
, Gow
J
. Gender-specific differences in care-seeking behaviour among lung cancer patients: a systematic review
. J Cancer Res Clin Oncol
. 2020
;146
(5
):1169
–96
.12.
Finke
I
, Behrens
G
, Schwettmann
L
, Gerken
M
, Pritzkuleit
R
, Holleczek
B
, Socioeconomic differences and lung cancer survival in Germany: investigation based on population-based clinical cancer registration
. Lung Cancer
. 2020
;142
:1
–8
.13.
Eberle
A
, Jansen
L
, Castro
F
, Krilaviciute
A
, Luttmann
S
, Emrich
K
, Lung cancer survival in Germany: a population-based analysis of 132,612 lung cancer patients
. Lung Cancer
. 2015
;90
(3
):528
–33
.14.
Forschungsdatenzentren der statistischen ämter des bundes und der länder: datenangebot. Fallpauschalenbezogene krankenhausstatistik (DRG-statistik). Wiesbaden: forschungsdatenzentren der statistischen ämter des bundes und der länder. [cited 2021 Sep 6]. Available from: www.forschungsdatenzentren.de/bestand/drg/index.asp.
15.
Diers
J
, Wagner
J
, Baum
P
, Lichthardt
S
, Kastner
C
, Matthes
N
, Nationwide in-hospital mortality following colonic cancer resection according to hospital volume in Germany
. BJS Open
. 2019
;3
(5
):672
–7
.16.
Baum
P
, Diers
J
, Lichthardt
S
, Kastner
C
, Schlegel
N
, Germer
CT
, Mortality and complications following visceral surgery
. Dtsch Arztebl Int
. 2019
;116
(44
):739
–46
.17.
Baum
P
, Diers
J
, Haag
J
, Klotz
L
, Eichhorn
F
, Eichhorn
M
, Nationwide effect of high procedure volume in lung cancer surgery on in-house mortality in Germany
. Lung Cancer
. 2020 Nov
;149
:78
–83
.18.
Baum
P
, Lenzi
J
, Diers
J
, Rust
C
, Eichhorn
ME
, Taber
S
, Risk-Adjusted Mortality Rates as a Quality Proxy Outperform Volume in Surgical Oncology-A New Perspective on Hospital Centralization Using National Population-Based Data
. J Clin Oncol
. 2022
;JCO2101488
. DOI: 10.1200/JCO.21.01488.19.
Benchimol
EI
, Smeeth
L
, Guttmann
A
, Harron
K
, Moher
D
, Petersen
I
, The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement
. PLoS Med
. 2015
;12
(10
):e1001885
.20.
Stausberg
J
, Hagn
S
. New morbidity and comorbidity scores based on the structure of the ICD-10
. PLoS One
. 2015
;10
(12
):e0143365
. .21.
Birkmeyer
JD
, Dimick
JB
. Understanding and reducing variation in surgical mortality
. Annu Rev Med
. 2009
;60
:405
–15
. .22.
Grewal
K
, Wijeysundera
DN
, Carroll
J
, Tait
G
, Beattie
WS
. Gender differences in mortality following non-cardiovascular surgery: an observational study
. Can J Anaesth
. 2012
;59
(3
):255
–62
.23.
Al-Taki
M
, Sukkarieh
HG
, Hoballah
JJ
, Jamali
SF
, Habbal
M
, Masrouha
KZ
, Effect of gender on postoperative morbidity and mortality outcomes: a retrospective cohort study
. Am Surg
. 2018
;84
(3
):377
–86
.24.
Damhuis
RA
, Schütte
PR
. Resection rates and postoperative mortality in 7,899 patients with lung cancer
. Eur Respir J
. 1996
;9
(1
):7
–10
. .25.
Lie
SA
, Engesaeter
LB
, Havelin
LI
, Furnes
O
, Vollset
SE
. Early postoperative mortality after 67,548 total hip replacements: causes of death and thromboprophylaxis in 68 hospitals in Norway from 1987 to 1999
. Acta Orthop Scand
. 2002
;73
(4
):392
–9
.26.
Wichmann
MW
, Inthorn
D
, Andress
HJ
, Schildberg
FW
. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome
. Intensive Care Med
. 2000
;26
(2
):167
–72
.27.
Trenner
M
, Kuehnl
A
, Reutersberg
B
, Salvermoser
M
, Eckstein
HH
. Nationwide analysis of risk factors for in-hospital mortality in patients undergoing abdominal aortic aneurysm repair
. Br J Surg
. 2018
;105
(4
):379
–87
.28.
Edwards
FH
, Carey
JS
, Grover
FL
, Bero
JW
, Hartz
RS
. Impact of gender on coronary bypass operative mortality
. Ann Thorac Surg
. 1998
;66
(1
):125
–31
.29.
Shah
R
, Newcomb
DC
. Sex bias in asthma prevalence and pathogenesis
. Front Immunol
. 2018
;9
:2997
. .30.
Postmus
PE
, Kerr
KM
, Oudkerk
M
, Senan
S
, Waller
DA
, Vansteenkiste
J
, Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up
. Ann Oncol
. 2017
;28
(Suppl 4
):iv1
–21
.31.
Barua
A
, Handagala
SD
, Socci
L
, Barua
B
, Malik
M
, Johnstone
N
, Accuracy of two scoring systems for risk stratification in thoracic surgery
. Interact Cardiovasc Thorac Surg
. 2012
;14
(5
):556
–9
.32.
Cavalheri
V
, Granger
C
. Preoperative exercise training for patients with non-small cell lung cancer
. Cochrane Database Syst Rev
. 2017
;6
:CD012020
. .© 2022 S. Karger AG, Basel
2022
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
